It's ALL about the patient

We believe every rare disease patient should be able to quickly receive an accurate diagnosis and the appropriate care they deserve. This is our mission.

We are accountable for your results

Really! Right after patients come our customers. We are here to help you get the results you need.

Compliance makes it all possible

Rare disease and the diagnostic odyssey are the enemies here, not compliance regulations. We believe in doing what is legally and morally right, including protecting patient privacy and maintaining legal compliance. We're here to make the system work for you and the patient.

Operational Team

Board, Investors & Advisors


Jeff Seraphine

BOARD MEMBER

Jeff has 23 years of experience in the hospital and healthcare services sector. He is currently the CEO of Arete Healthcare, a healthcare information technology company that has developed and implemented its own proprietary EHR application, in addition to providing comprehensive billing services, practice management software, and patient portal applications. He previously served as the Chief Development Officer of LifePoint Health and also worked as President/SVP of LifePoint Health’s Eastern and Delta Divisions, President of Duke LifePoint, LLC, and CEO/COO/President of three acute care hospitals (two of which were LifePoint Health affiliated.)

Jeff earned both his Master’s degree in Healthcare Administration and undergraduate BBA in Management and Marketing from the University of Kentucky. He is also a fellow of the Nashville Healthcare Council.

Jeff Patton

INVESTOR AND ADVISOR

Dr. Jeff Patton is a board-certified hematologist and oncologist, Chief Executive Officer and Board Member at OneOncology, where he also served as President of Physician Services for over a year. His primary mission is to improve the lives of everyone living with cancer and is leading OneOncology in advancing the partnership of top community oncology practices and positioning them to support the entire continuum of cancer care in any reimbursement environment.

Dr. Patton practiced with Tennessee Oncology, one of the nation’s leading oncology practices, for 24 years. He is currently the Executive Chairman of the Board and served as CEO of Tennessee Oncology for a decade (2010-2020). Dr. Patton is also an active member of the American Society of Clinical Oncology (ASCO), Tennessee Oncology Practice Society (TOPS), and serves as Chairman of the Community Oncology Alliance (COA).

Bruce Brandes

ADVISOR

Bruce has 30 years of experience in executive management and entrepreneurial thought leadership to build growth stage technology-based businesses in the healthcare industry. He currently serves as Senior Vice President, Consumer Centered Virtual Care at Teladoc. Most recently, Bruce worked to simplify, accelerate and scale health system adoption of digital solutions as Executive in Residence at AVIA, Founder & CEO of Lucro and Managing Director of Martin Ventures.

Mark Smith

INVESTOR AND BOARD MEMBER

Mark is the Owner, Secretary/Treasurer, and Chief Compliance Officer of Lee, Danner, and Bass, Inc., a financial management firm with 1.2 Billion in regulatory assets under management on behalf of individuals, endowment funds, retirement accounts, foundations, sponsors of employee benefit funds and corporations. He was previously associated with KPMG Peat Marwick. Mark earned dual degrees in Accounting and Management Information Systems from James Madison University. He is a Certified Public Accountant and a member of the CFA Institute.